Procalcitonin and Pentraxin-3: Current biomarkers in inflammation in white coat hypertension

An association has been described between inflammation and the progression of hypertension (HT) and is shown with several biochemical parameters. Our aim was to examine the distribution of the serum procalcitonin (PCT), pentraxin (PTX)-3 and interleukin (IL)-33 levels and their relationship with car...

Full description

Saved in:
Bibliographic Details
Published inJournal of human hypertension Vol. 30; no. 7; pp. 424 - 429
Main Authors Yavuzer, H, Cengiz, M, Yavuzer, S, Rıza Altıparmak, M, Korkmazer, B, Balci, H, Yaldıran, A L, Uzun, H
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.07.2016
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN0950-9240
1476-5527
1476-5527
DOI10.1038/jhh.2015.59

Cover

Loading…
Abstract An association has been described between inflammation and the progression of hypertension (HT) and is shown with several biochemical parameters. Our aim was to examine the distribution of the serum procalcitonin (PCT), pentraxin (PTX)-3 and interleukin (IL)-33 levels and their relationship with carotid intima–media thickness (CIMT) in subjects with white coat HT (WCH), HT and normotension (NT) groups. Thirty-three patients with HT, 33 patients with WCH and 33 healthy subjects were enrolled in this study. PCT, PTX-3 and C-reactive protein (CRP) levels significantly increased in the HT group compared with the NT group. In addition, PCT and CRP levels were significantly higher in the WCH group than in the NT group. CIMT measurements were significantly higher in the WCH and HT groups than in the NT group. In the HT and WCH groups, there were significant positive correlations between PTX-3, PCT and CRP. In the WCH group, PTX-3 and PCT levels were significantly positively correlated with CIMT. PCT had area under the curve value of 0.817 which demonstrates its sufficiency to distinguish WCH from NT individuals. Our results suggest that in subjects with WCH and HT, which are characterized by increased cardiovascular risk, PTX-3 and PCT levels in the HT group and PCT levels in the WCH group are significantly and consistently higher than normotensives. Systemic inflammation moderately occurs in the WCH and HT groups. PCT monitoring may be a useful biomarker in inflammation related to atherosclerosis and early stage HT.
AbstractList An association has been described between inflammation and the progression of hypertension (HT) and is shown with several biochemical parameters. Our aim was to examine the distribution of the serum procalcitonin (PCT), pentraxin (PTX)-3 and interleukin (IL)-33 levels and their relationship with carotid intima-media thickness (CIMT) in subjects with white coat HT (WCH), HT and normotension (NT) groups. Thirty-three patients with HT, 33 patients with WCH and 33 healthy subjects were enrolled in this study. PCT, PTX-3 and C-reactive protein (CRP) levels significantly increased in the HT group compared with the NT group. In addition, PCT and CRP levels were significantly higher in the WCH group than in the NT group. CIMT measurements were significantly higher in the WCH and HT groups than in the NT group. In the HT and WCH groups, there were significant positive correlations between PTX-3, PCT and CRP. In the WCH group, PTX-3 and PCT levels were significantly positively correlated with CIMT. PCT had area under the curve value of 0.817 which demonstrates its sufficiency to distinguish WCH from NT individuals. Our results suggest that in subjects with WCH and HT, which are characterized by increased cardiovascular risk, PTX-3 and PCT levels in the HT group and PCT levels in the WCH group are significantly and consistently higher than normotensives. Systemic inflammation moderately occurs in the WCH and HT groups. PCT monitoring may be a useful biomarker in inflammation related to atherosclerosis and early stage HT.
An association has been described between inflammation and the progression of hypertension (HT) and is shown with several biochemical parameters. Our aim was to examine the distribution of the serum procalcitonin (PCT), pentraxin (PTX)-3 and interleukin (IL)-33 levels and their relationship with carotid intima-media thickness (CIMT) in subjects with white coat HT (WCH), HT and normotension (NT) groups. Thirty-three patients with HT, 33 patients with WCH and 33 healthy subjects were enrolled in this study. PCT, PTX-3 and C-reactive protein (CRP) levels significantly increased in the HT group compared with the NT group. In addition, PCT and CRP levels were significantly higher in the WCH group than in the NT group. CIMT measurements were significantly higher in the WCH and HT groups than in the NT group. In the HT and WCH groups, there were significant positive correlations between PTX-3, PCT and CRP. In the WCH group, PTX-3 and PCT levels were significantly positively correlated with CIMT. PCT had area under the curve value of 0.817 which demonstrates its sufficiency to distinguish WCH from NT individuals. Our results suggest that in subjects with WCH and HT, which are characterized by increased cardiovascular risk, PTX-3 and PCT levels in the HT group and PCT levels in the WCH group are significantly and consistently higher than normotensives. Systemic inflammation moderately occurs in the WCH and HT groups. PCT monitoring may be a useful biomarker in inflammation related to atherosclerosis and early stage HT. Journal of Human Hypertension (2016) 30, 424-429; doi: 10.1038/jhh.2015.59; published online 4 June 2015
An association has been described between inflammation and the progression of hypertension (HT) and is shown with several biochemical parameters. Our aim was to examine the distribution of the serum procalcitonin (PCT), pentraxin (PTX)-3 and interleukin (IL)-33 levels and their relationship with carotid intima-media thickness (CIMT) in subjects with white coat HT (WCH), HT and normotension (NT) groups. Thirty-three patients with HT, 33 patients with WCH and 33 healthy subjects were enrolled in this study. PCT, PTX-3 and C-reactive protein (CRP) levels significantly increased in the HT group compared with the NT group. In addition, PCT and CRP levels were significantly higher in the WCH group than in the NT group. CIMT measurements were significantly higher in the WCH and HT groups than in the NT group. In the HT and WCH groups, there were significant positive correlations between PTX-3, PCT and CRP. In the WCH group, PTX-3 and PCT levels were significantly positively correlated with CIMT. PCT had area under the curve value of 0.817 which demonstrates its sufficiency to distinguish WCH from NT individuals. Our results suggest that in subjects with WCH and HT, which are characterized by increased cardiovascular risk, PTX-3 and PCT levels in the HT group and PCT levels in the WCH group are significantly and consistently higher than normotensives. Systemic inflammation moderately occurs in the WCH and HT groups. PCT monitoring may be a useful biomarker in inflammation related to atherosclerosis and early stage HT.An association has been described between inflammation and the progression of hypertension (HT) and is shown with several biochemical parameters. Our aim was to examine the distribution of the serum procalcitonin (PCT), pentraxin (PTX)-3 and interleukin (IL)-33 levels and their relationship with carotid intima-media thickness (CIMT) in subjects with white coat HT (WCH), HT and normotension (NT) groups. Thirty-three patients with HT, 33 patients with WCH and 33 healthy subjects were enrolled in this study. PCT, PTX-3 and C-reactive protein (CRP) levels significantly increased in the HT group compared with the NT group. In addition, PCT and CRP levels were significantly higher in the WCH group than in the NT group. CIMT measurements were significantly higher in the WCH and HT groups than in the NT group. In the HT and WCH groups, there were significant positive correlations between PTX-3, PCT and CRP. In the WCH group, PTX-3 and PCT levels were significantly positively correlated with CIMT. PCT had area under the curve value of 0.817 which demonstrates its sufficiency to distinguish WCH from NT individuals. Our results suggest that in subjects with WCH and HT, which are characterized by increased cardiovascular risk, PTX-3 and PCT levels in the HT group and PCT levels in the WCH group are significantly and consistently higher than normotensives. Systemic inflammation moderately occurs in the WCH and HT groups. PCT monitoring may be a useful biomarker in inflammation related to atherosclerosis and early stage HT.
Audience Academic
Author Yavuzer, S
Uzun, H
Rıza Altıparmak, M
Yaldıran, A L
Yavuzer, H
Balci, H
Korkmazer, B
Cengiz, M
Author_xml – sequence: 1
  givenname: H
  surname: Yavuzer
  fullname: Yavuzer, H
  organization: Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University
– sequence: 2
  givenname: M
  surname: Cengiz
  fullname: Cengiz, M
  organization: Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University
– sequence: 3
  givenname: S
  surname: Yavuzer
  fullname: Yavuzer, S
  email: drserapsahin@gmail.com
  organization: Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University
– sequence: 4
  givenname: M
  surname: Rıza Altıparmak
  fullname: Rıza Altıparmak, M
  organization: Department of Nephrology, , Cerrahpasa Medical Faculty, Istanbul University
– sequence: 5
  givenname: B
  surname: Korkmazer
  fullname: Korkmazer, B
  organization: Department of Radiology, Cerrahpasa Medical Faculty, Istanbul University
– sequence: 6
  givenname: H
  surname: Balci
  fullname: Balci, H
  organization: Central Research Laboratory, Cerrahpasa Medical Faculty, Istanbul University
– sequence: 7
  givenname: A L
  surname: Yaldıran
  fullname: Yaldıran, A L
  organization: Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University
– sequence: 8
  givenname: H
  surname: Uzun
  fullname: Uzun, H
  organization: Department of Biochemistry, Cerrahpasa Medical Faculty, Istanbul University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26040439$$D View this record in MEDLINE/PubMed
BookMark eNqFkt9rFDEQx4NU7LX65LssCCLonpNfu4lvx-EvKNgHfRNCNpvt5dxNzmQX7X9v1mvxLIclD8NkPjPJzHzP0IkP3iL0FMMSAxVvtpvNkgDmSy4foAVmdVVyTuoTtADJoZSEwSk6S2kLMAfFI3RKKmDAqFygb5cxGN0bNwbvfKF9W1xaP0b9y_mSvi3WU4zZLxoXBh2_25iKjDnf9XoY9OjC7BQ_N260hQl6LDbXOxtH61MOPUYPO90n--TGnqOv7999WX8sLz5_-LReXZSGMzaWTHZCGNk2pGuFENmwhtS25RRqabNLuaFtRyxpWi06CVJg2lQGrCQUN4aeo5f7ursYfkw2jWpwydi-196GKSksQFSEcKD3o7XkoqpxRTL6_A66DVP0uRFFKgYVBS7_S-VajMncA_ylrnRvVR5fyCM289NqxXgFktWUZ2p5hMqntYMzeeudy_f_JLw4SNhY3Y-bFPpp3ktSq4oD8BrXcB94WPHZTTtTM9hW7aLLe79Wt4rJAN4DJoaUou1U1s4fIeS_ul5hULMqVValmlWp-Jzz6k7Obdnj9Os9nTLlr2w8mOgR_DeJpu0R
CitedBy_id crossref_primary_10_1111_jch_13273
crossref_primary_10_14814_phy2_70086
crossref_primary_10_18705_1607_419X_2023_29_2_124_137
crossref_primary_10_1097_HJH_0000000000003073
crossref_primary_10_1515_tjb_2022_0237
crossref_primary_10_1038_s41371_019_0250_7
crossref_primary_10_1111_jch_12882
crossref_primary_10_32322_jhsm_969699
Cites_doi 10.3109/08037051.2012.745226
10.5543/tkda.2013.20025
10.1093/gerona/glq030
10.1111/j.1365-2796.2012.02548.x
10.1161/01.CIR.98.8.731
10.1093/ndt/gfl019
10.1253/circj.CJ-10-0638
10.1097/MBP.0b013e3283651d19
10.1189/jlb.1005557
10.1097/HJH.0b013e328360ddd5
10.1136/bmj.322.7285.531
10.1055/s-0033-1348880
10.1001/jama.2009.943
10.1182/blood-2009-02-203372
10.1001/jama.290.22.2945
10.1084/jem.20071868
10.2337/dc08-s246
10.1016/j.jash.2011.03.004
10.1177/147323001003800106
10.1161/01.CIR.74.6.1399
10.1161/01.HYP.0000146691.51307.84
10.1186/1476-9255-8-22
10.1536/ihj.13-253
10.1097/00004872-200105000-00004
10.1161/ATVBAHA.111.231431
10.1016/S0895-7061(03)00566-1
10.1161/hh2101.099270
10.1136/bmj.320.7242.1128
10.1001/jama.1988.03720020027031
ContentType Journal Article
Copyright Macmillan Publishers Limited 2016
COPYRIGHT 2016 Nature Publishing Group
Copyright Nature Publishing Group Jul 2016
Macmillan Publishers Limited 2016.
Copyright_xml – notice: Macmillan Publishers Limited 2016
– notice: COPYRIGHT 2016 Nature Publishing Group
– notice: Copyright Nature Publishing Group Jul 2016
– notice: Macmillan Publishers Limited 2016.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7X7
7XB
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1038/jhh.2015.59
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Collection (ProQuest)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni)
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
ProQuest Central Student


MEDLINE - Academic
MEDLINE
ProQuest Central Student


AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1476-5527
EndPage 429
ExternalDocumentID 4081194661
A456094735
A650057170
26040439
10_1038_jhh_2015_59
Genre Journal Article
GeographicLocations Turkey
GeographicLocations_xml – name: Turkey
GroupedDBID ---
-Q-
0R~
29K
2WC
36B
39C
3V.
4.4
406
53G
5GY
5RE
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
A8Z
AACDK
AANZL
AASML
AATNV
AAYZH
AAZLF
ABAKF
ABAWZ
ABCQX
ABDBF
ABJNI
ABLJU
ABOCM
ABUWG
ABZZP
ACAOD
ACGFS
ACKTT
ACPRK
ACRQY
ACUHS
ACZOJ
ADBBV
ADHDB
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AFBBN
AFKRA
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AIGIU
AILAN
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AXYYD
B0M
BAWUL
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
D-I
DIK
DNIVK
DPUIP
DU5
E3Z
EAD
EAP
EBC
EBD
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
HCIFZ
HMCUK
HZ~
IAO
IHR
IHW
INH
INR
ITC
IWAJR
JSO
JZLTJ
KQ8
L7B
M1P
M7P
NAO
NQJWS
O9-
OK1
OVD
P2P
PQQKQ
PROAC
PSQYO
Q2X
RNS
RNT
RNTTT
ROL
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
TUS
UKHRP
W2D
YYP
ZXP
~8M
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
AEIIB
PMFND
7T5
7XB
8FE
8FH
8FK
ABRTQ
AZQEC
DWQXO
GNUQQ
H94
K9.
LK8
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7X8
PUEGO
ID FETCH-LOGICAL-c544t-49f88c9db2fd888b2f4b27ed53079eb2f35c3df2e2bda8f909813b6c0e9231bc3
IEDL.DBID BENPR
ISSN 0950-9240
1476-5527
IngestDate Thu Sep 04 22:01:53 EDT 2025
Thu Sep 04 22:57:15 EDT 2025
Sat Aug 23 12:48:06 EDT 2025
Fri Jul 25 09:11:50 EDT 2025
Tue Jun 17 21:35:44 EDT 2025
Tue Jun 10 20:47:09 EDT 2025
Thu May 22 21:32:51 EDT 2025
Thu May 22 21:04:41 EDT 2025
Thu Apr 03 07:05:32 EDT 2025
Thu Apr 24 23:03:12 EDT 2025
Tue Jul 01 03:25:31 EDT 2025
Fri Feb 21 02:39:44 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c544t-49f88c9db2fd888b2f4b27ed53079eb2f35c3df2e2bda8f909813b6c0e9231bc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 26040439
PQID 1794490790
PQPubID 35973
PageCount 6
ParticipantIDs proquest_miscellaneous_1808622503
proquest_miscellaneous_1795867162
proquest_journals_2640630592
proquest_journals_1794490790
gale_infotracmisc_A456094735
gale_infotracacademiconefile_A456094735
gale_healthsolutions_A650057170
gale_healthsolutions_A456094735
pubmed_primary_26040439
crossref_citationtrail_10_1038_jhh_2015_59
crossref_primary_10_1038_jhh_2015_59
springer_journals_10_1038_jhh_2015_59
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-07-01
PublicationDateYYYYMMDD 2016-07-01
PublicationDate_xml – month: 07
  year: 2016
  text: 2016-07-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Journal of human hypertension
PublicationTitleAbbrev J Hum Hypertens
PublicationTitleAlternate J Hum Hypertens
PublicationYear 2016
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Niskanen, Laaksonen, Nyyssönen, Punnonen, Valkonen, Fuentes (CR24) 2004; 44
Ataoglu, Yilmaz, Uzunhasan, Cetin, Temiz, Döventaş (CR32) 2010; 38
Sinning, Sinning, Schulz, Schnabel, Lubos, Wild (CR9) 2011; 75
Miller, Xu, Asquith, Denby, Li, Sattar (CR34) 2008; 205
Yasunaga, Ikeda, Koga, Nakata, Yoshida, Masuda (CR6) 2014; 55
Mallamaci, Leonardis, Pizzini, Cutrupi, Tripepi, Zoccali (CR10) 2013; 31
Demyanets, Konya, Kastl, Kaun, Rauscher, Niessner (CR11) 2011; 31
Melander, Newton-Cheh, Almgren, Hedblad, Berglund, Engström (CR19) 2009; 302
Zhang, Wang, Wang, Tong, Zhang (CR18) 2013; 22
Savoia, Schiffrin (CR1) 2006; 15
Peer, Boaz, Zipora, Shargorodsky (CR25) 2013; 22
Ozdogan, Bozcuk, Coban (CR22) 2007; 13
Bautista, López-Jaramillo, Vera, Casas, Otero, Guaracao (CR21) 2001; 19
O'Brien, Waeber, Parati, Staessen, Myers (CR13) 2001; 322
O'Brien, Coats, Owens, Petrie, Padfield, Littler (CR14) 2000; 320
Ridker, Buring, Shih, Matias, Hennekens (CR5) 1998; 98
Dandona, Nix, Wilson, Aljada, Love, Assicot (CR8) 1994; 79
Pauletto, Rattazzi (CR16) 2006; 21
Büyükkaya, Karakaş, Kurt, Motor, Akçay, Büyükkaya (CR30) 2013; 41
Grossman (CR2) 2008; 31
Pickering, James, Boddie, Harshfield, Blank, Laragh (CR3) 1988; 259
Amer, Elawam, Khater, Omar, Mabrouk, Taha (CR27) 2011; 5
Lu, Guo, Hu, Wu, Zhou, Zhou (CR17) 2013; 47
Turak, Özcan, Canpolat, Işleyen, Cebeci, Öksüz (CR26) 2013; 18
Blake, Ridker (CR4) 2001; 89
Yano, Matsuda, Hatakeyama, Sato, Imamura, Shimada (CR31) 2010; 65
Gupta, Sachdeva, Khan, Haque (CR28) 2011; 22
Pignoli, Tremoli, Poli, Oreste, Paoletti (CR15) 1986; 74
Miller (CR12) 2011; 8
Sung, Suh, Kim, Kang, Kim, Lee (CR20) 2003; 16
Sesso, Buring, Rifai, Blake, Gaziano, Ridker (CR23) 2003; 290
Parlak, Aydoğan, Iyisoy, Dikililer, Kut, Cakır (CR29) 2012; 12
Bottazzi, Bastone, Doni, Garlanda, Valentino, Deban (CR7) 2006; 79
Choi, Choi, Min, Pyun, Maeng, Park (CR35) 2009; 114
Schiopu, Hedblad, Engström, Struck, Morgenthaler, Melander (CR33) 2012; 272
E O'Brien (BFjhh201559_CR13) 2001; 322
O Melander (BFjhh201559_CR19) 2009; 302
E O'Brien (BFjhh201559_CR14) 2000; 320
HD Sesso (BFjhh201559_CR23) 2003; 290
B Bottazzi (BFjhh201559_CR7) 2006; 79
P Pauletto (BFjhh201559_CR16) 2006; 21
CR Sinning (BFjhh201559_CR9) 2011; 75
L Niskanen (BFjhh201559_CR24) 2004; 44
Y Yano (BFjhh201559_CR31) 2010; 65
E Grossman (BFjhh201559_CR2) 2008; 31
V Gupta (BFjhh201559_CR28) 2011; 22
AM Miller (BFjhh201559_CR12) 2011; 8
LE Bautista (BFjhh201559_CR21) 2001; 19
TG Pickering (BFjhh201559_CR3) 1988; 259
PM Ridker (BFjhh201559_CR5) 1998; 98
AM Miller (BFjhh201559_CR34) 2008; 205
HH Lu (BFjhh201559_CR17) 2013; 47
P Dandona (BFjhh201559_CR8) 1994; 79
KC Sung (BFjhh201559_CR20) 2003; 16
A Parlak (BFjhh201559_CR29) 2012; 12
S Demyanets (BFjhh201559_CR11) 2011; 31
P Pignoli (BFjhh201559_CR15) 1986; 74
GJ Blake (BFjhh201559_CR4) 2001; 89
M Peer (BFjhh201559_CR25) 2013; 22
HE Ataoglu (BFjhh201559_CR32) 2010; 38
T Yasunaga (BFjhh201559_CR6) 2014; 55
M Zhang (BFjhh201559_CR18) 2013; 22
E Büyükkaya (BFjhh201559_CR30) 2013; 41
C Savoia (BFjhh201559_CR1) 2006; 15
O Turak (BFjhh201559_CR26) 2013; 18
YS Choi (BFjhh201559_CR35) 2009; 114
F Mallamaci (BFjhh201559_CR10) 2013; 31
MS Amer (BFjhh201559_CR27) 2011; 5
A Schiopu (BFjhh201559_CR33) 2012; 272
M Ozdogan (BFjhh201559_CR22) 2007; 13
19567439 - JAMA. 2009 Jul 1;302(1):49-57
16464884 - Nephrol Dial Transplant. 2006 Apr;21(4):850-3
24436616 - Int J Angiol. 2013 Dec;22(4):223-8
12799089 - Am J Hypertens. 2003 Jun;16(6):429-33
7989463 - J Clin Endocrinol Metab. 1994 Dec;79(6):1605-8
22530956 - J Intern Med. 2012 Nov;272(5):484-91
23949417 - Blood Press Monit. 2013 Oct;18(5):259-64
18049438 - Med Sci Monit. 2007 Dec;13(12):CR570-3
15492131 - Hypertension. 2004 Dec;44(6):859-65
24507232 - Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Nov;47(11):1026-30
18268038 - J Exp Med. 2008 Feb 18;205(2):339-46
21524639 - J Am Soc Hypertens. 2011 Sep-Oct;5(5):395-400
16481882 - Curr Opin Nephrol Hypertens. 2006 Mar;15(2):152-8
11393667 - J Hypertens. 2001 May;19(5):857-61
21871091 - J Inflamm (Lond). 2011 Aug 26;8(1):22
16478917 - J Leukoc Biol. 2006 May;79(5):909-12
11230071 - BMJ. 2001 Mar 3;322(7285):531-6
20233513 - J Int Med Res. 2010 Jan-Feb;38(1):52-61
21378450 - Circ J. 2011;75(5):1184-91
10775227 - BMJ. 2000 Apr 22;320(7242):1128-34
21196621 - Saudi J Kidney Dis Transpl. 2011 Jan;22(1):97-103
14665655 - JAMA. 2003 Dec 10;290(22):2945-51
3536154 - Circulation. 1986 Dec;74(6):1399-406
19661270 - Blood. 2009 Oct 1;114(14 ):3117-26
21737781 - Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2080-9
23210729 - Blood Press. 2013 Jun;22(3):151-7
11679405 - Circ Res. 2001 Oct 26;89(9):763-71
3336140 - JAMA. 1988 Jan 8;259(2):225-8
20203097 - J Gerontol A Biol Sci Med Sci. 2010 May;65(5):547-52
23743803 - J Hypertens. 2013 Jul;31(7):1424-30; discussion 1430
9727541 - Circulation. 1998 Aug 25;98(8):731-3
23760115 - Turk Kardiyol Dern Ars. 2013 Jun;41(4):290-5
22466361 - Anadolu Kardiyol Derg. 2012 Jun;12(4):298-304
18227483 - Diabetes Care. 2008 Feb;31 Suppl 2:S185-9
24632958 - Int Heart J. 2014;55(2):160-4
References_xml – volume: 15
  start-page: 152
  year: 2006
  end-page: 158
  ident: CR1
  article-title: Inflammation in hypertension
  publication-title: Curr Opin Nephrol Hypertens
– volume: 22
  start-page: 151
  year: 2013
  end-page: 157
  ident: CR18
  article-title: Association of hypertension with coexistence of abnormal metabolism and inflammation and endothelial dysfunction
  publication-title: Blood Press
  doi: 10.3109/08037051.2012.745226
– volume: 41
  start-page: 290
  year: 2013
  end-page: 295
  ident: CR30
  article-title: The serum pentraxin-3 is elevated in patients with cardiac syndrome X
  publication-title: Turk Kardiyol Dern Ars
  doi: 10.5543/tkda.2013.20025
– volume: 65
  start-page: 547
  year: 2010
  end-page: 552
  ident: CR31
  article-title: Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients
  publication-title: J Gerontol A Biol Sci Med Sci
  doi: 10.1093/gerona/glq030
– volume: 272
  start-page: 484
  year: 2012
  end-page: 491
  ident: CR33
  article-title: Plasma procalcitonin and the risk of cardiovascular events and death: a prospective population-based study
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.2012.02548.x
– volume: 98
  start-page: 731
  year: 1998
  end-page: 733
  ident: CR5
  article-title: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
  publication-title: Circulation
  doi: 10.1161/01.CIR.98.8.731
– volume: 21
  start-page: 850
  year: 2006
  end-page: 853
  ident: CR16
  article-title: Inflammation and hypertension: the search for a link
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfl019
– volume: 75
  start-page: 1184
  year: 2011
  end-page: 1191
  ident: CR9
  article-title: AtheroGene Study Investigators. Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease
  publication-title: Circ J
  doi: 10.1253/circj.CJ-10-0638
– volume: 18
  start-page: 259
  year: 2013
  end-page: 264
  ident: CR26
  article-title: Increased echocardiographic epicardial fat thickness and high-sensitivity CRP level indicate diastolic dysfunction in patients with newly diagnosed essential hypertension
  publication-title: Blood Press Monit
  doi: 10.1097/MBP.0b013e3283651d19
– volume: 79
  start-page: 1605
  year: 1994
  end-page: 1608
  ident: CR8
  article-title: Procalcitonin increase after endotoxin injection in normal subjects
  publication-title: J Clin Endocrinol Metab
– volume: 12
  start-page: 298
  year: 2012
  end-page: 304
  ident: CR29
  article-title: Elevated pentraxin-3 levels are related to blood pressure levels in hypertensive patients: an observational study
  publication-title: Anadolu Kardiyol Derg
– volume: 79
  start-page: 909
  year: 2006
  end-page: 912
  ident: CR7
  article-title: The long pentraxin PTX3 as a link among innate immunity, inflamatıon and female fertility
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.1005557
– volume: 31
  start-page: 1424
  year: 2013
  end-page: 1430
  ident: CR10
  article-title: Procalcitonin and the inflammatory response to salt in essential hypertension: a randomized cross-over clinical trial
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e328360ddd5
– volume: 322
  start-page: 531
  year: 2001
  end-page: 536
  ident: CR13
  article-title: Blood pressure measuring devices: recommendations of the European Society of Hypertension
  publication-title: BMJ
  doi: 10.1136/bmj.322.7285.531
– volume: 22
  start-page: 223
  year: 2013
  end-page: 228
  ident: CR25
  article-title: Determinants of left ventricular hypertrophy in hypertensive patients: identification of high-risk patients by metabolic, vascular, and inflammatory risk factors
  publication-title: Int J Angiol
  doi: 10.1055/s-0033-1348880
– volume: 302
  start-page: 49
  year: 2009
  end-page: 57
  ident: CR19
  article-title: Novel and conventional biomarkers for prediction of incident cardiovascular events in the community
  publication-title: JAMA
  doi: 10.1001/jama.2009.943
– volume: 114
  start-page: 3117
  year: 2009
  end-page: 3126
  ident: CR35
  article-title: Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production
  publication-title: Blood
  doi: 10.1182/blood-2009-02-203372
– volume: 47
  start-page: 1026
  year: 2013
  end-page: 1030
  ident: CR17
  article-title: The prospective study of association between C-reactive protein and hypertension in community population
  publication-title: Zhonghua Yu Fang Yi Xue Za Zhi
– volume: 290
  start-page: 2945
  year: 2003
  end-page: 2951
  ident: CR23
  article-title: C-reactive protein and the risk of developing hypertension
  publication-title: JAMA
  doi: 10.1001/jama.290.22.2945
– volume: 205
  start-page: 339
  year: 2008
  end-page: 346
  ident: CR34
  article-title: IL-33 reduces the development of atherosclerosis
  publication-title: J Exp Med
  doi: 10.1084/jem.20071868
– volume: 13
  start-page: CR570
  year: 2007
  end-page: CR573
  ident: CR22
  article-title: Low-grade inflammation in white-coat hypertension
  publication-title: Med Sci Monit
– volume: 31
  start-page: S185
  year: 2008
  end-page: S189
  ident: CR2
  article-title: Does increased oxidative stress cause hypertension?
  publication-title: Diabetes Care
  doi: 10.2337/dc08-s246
– volume: 5
  start-page: 395
  year: 2011
  end-page: 400
  ident: CR27
  article-title: Association of high-sensitivity C-reactive protein with carotid artery intima-media thickness in hypertensive older adults
  publication-title: J Am Soc Hypertens
  doi: 10.1016/j.jash.2011.03.004
– volume: 38
  start-page: 52
  year: 2010
  end-page: 61
  ident: CR32
  article-title: Procalcitonin: a novel cardiac marker with prognostic value in acute coronary syndrome
  publication-title: J Int Med Res
  doi: 10.1177/147323001003800106
– volume: 74
  start-page: 1399
  year: 1986
  end-page: 1406
  ident: CR15
  article-title: Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging
  publication-title: Circulation
  doi: 10.1161/01.CIR.74.6.1399
– volume: 44
  start-page: 859
  year: 2004
  end-page: 865
  ident: CR24
  article-title: Inflammation, abdominal obesity, and smoking as predictors of hypertension
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000146691.51307.84
– volume: 8
  start-page: 22
  year: 2011
  ident: CR12
  article-title: Role of IL-33 in inflammation and disease
  publication-title: J Inflamm (Lond)
  doi: 10.1186/1476-9255-8-22
– volume: 55
  start-page: 160
  year: 2014
  end-page: 164
  ident: CR6
  article-title: Plasma pentraxin 3 is a more potent predictor of endothelial dysfunction than high-sensitive C-reactive protein
  publication-title: Int Heart J
  doi: 10.1536/ihj.13-253
– volume: 19
  start-page: 857
  year: 2001
  end-page: 861
  ident: CR21
  article-title: Is C-reactive protein an independent risk factor for essential hypertension?
  publication-title: J Hypertens
  doi: 10.1097/00004872-200105000-00004
– volume: 31
  start-page: 2080
  year: 2011
  end-page: 2089
  ident: CR11
  article-title: Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.111.231431
– volume: 16
  start-page: 429
  year: 2003
  end-page: 433
  ident: CR20
  article-title: High sensitivity C-reactive protein as an independent risk factor for essential hypertension
  publication-title: Am J Hypertens
  doi: 10.1016/S0895-7061(03)00566-1
– volume: 89
  start-page: 763
  year: 2001
  end-page: 771
  ident: CR4
  article-title: Novel clinical markers of vascular wall inflammation
  publication-title: Circ Res
  doi: 10.1161/hh2101.099270
– volume: 320
  start-page: 1128
  year: 2000
  end-page: 1134
  ident: CR14
  article-title: Use and interpretation of Ambulatory blood pressure monitoring: recommendations of the British Hypertension Society
  publication-title: BMJ
  doi: 10.1136/bmj.320.7242.1128
– volume: 22
  start-page: 97
  year: 2011
  end-page: 103
  ident: CR28
  article-title: Endothelial dysfunction and inflammation in different stages of essential hypertension
  publication-title: Saudi J Kidney Dis Transpl
– volume: 259
  start-page: 225
  year: 1988
  end-page: 228
  ident: CR3
  article-title: How common is white coat hypertension?
  publication-title: JAMA
  doi: 10.1001/jama.1988.03720020027031
– volume: 22
  start-page: 151
  year: 2013
  ident: BFjhh201559_CR18
  publication-title: Blood Press
  doi: 10.3109/08037051.2012.745226
– volume: 13
  start-page: CR570
  year: 2007
  ident: BFjhh201559_CR22
  publication-title: Med Sci Monit
– volume: 55
  start-page: 160
  year: 2014
  ident: BFjhh201559_CR6
  publication-title: Int Heart J
  doi: 10.1536/ihj.13-253
– volume: 18
  start-page: 259
  year: 2013
  ident: BFjhh201559_CR26
  publication-title: Blood Press Monit
  doi: 10.1097/MBP.0b013e3283651d19
– volume: 89
  start-page: 763
  year: 2001
  ident: BFjhh201559_CR4
  publication-title: Circ Res
  doi: 10.1161/hh2101.099270
– volume: 31
  start-page: S185
  year: 2008
  ident: BFjhh201559_CR2
  publication-title: Diabetes Care
  doi: 10.2337/dc08-s246
– volume: 31
  start-page: 2080
  year: 2011
  ident: BFjhh201559_CR11
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.111.231431
– volume: 302
  start-page: 49
  year: 2009
  ident: BFjhh201559_CR19
  publication-title: JAMA
  doi: 10.1001/jama.2009.943
– volume: 22
  start-page: 223
  year: 2013
  ident: BFjhh201559_CR25
  publication-title: Int J Angiol
  doi: 10.1055/s-0033-1348880
– volume: 15
  start-page: 152
  year: 2006
  ident: BFjhh201559_CR1
  publication-title: Curr Opin Nephrol Hypertens
– volume: 22
  start-page: 97
  year: 2011
  ident: BFjhh201559_CR28
  publication-title: Saudi J Kidney Dis Transpl
– volume: 8
  start-page: 22
  year: 2011
  ident: BFjhh201559_CR12
  publication-title: J Inflamm (Lond)
  doi: 10.1186/1476-9255-8-22
– volume: 38
  start-page: 52
  year: 2010
  ident: BFjhh201559_CR32
  publication-title: J Int Med Res
  doi: 10.1177/147323001003800106
– volume: 5
  start-page: 395
  year: 2011
  ident: BFjhh201559_CR27
  publication-title: J Am Soc Hypertens
  doi: 10.1016/j.jash.2011.03.004
– volume: 272
  start-page: 484
  year: 2012
  ident: BFjhh201559_CR33
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.2012.02548.x
– volume: 205
  start-page: 339
  year: 2008
  ident: BFjhh201559_CR34
  publication-title: J Exp Med
  doi: 10.1084/jem.20071868
– volume: 79
  start-page: 909
  year: 2006
  ident: BFjhh201559_CR7
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.1005557
– volume: 79
  start-page: 1605
  year: 1994
  ident: BFjhh201559_CR8
  publication-title: J Clin Endocrinol Metab
– volume: 290
  start-page: 2945
  year: 2003
  ident: BFjhh201559_CR23
  publication-title: JAMA
  doi: 10.1001/jama.290.22.2945
– volume: 21
  start-page: 850
  year: 2006
  ident: BFjhh201559_CR16
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfl019
– volume: 12
  start-page: 298
  year: 2012
  ident: BFjhh201559_CR29
  publication-title: Anadolu Kardiyol Derg
– volume: 44
  start-page: 859
  year: 2004
  ident: BFjhh201559_CR24
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000146691.51307.84
– volume: 98
  start-page: 731
  year: 1998
  ident: BFjhh201559_CR5
  publication-title: Circulation
  doi: 10.1161/01.CIR.98.8.731
– volume: 322
  start-page: 531
  year: 2001
  ident: BFjhh201559_CR13
  publication-title: BMJ
  doi: 10.1136/bmj.322.7285.531
– volume: 320
  start-page: 1128
  year: 2000
  ident: BFjhh201559_CR14
  publication-title: BMJ
  doi: 10.1136/bmj.320.7242.1128
– volume: 31
  start-page: 1424
  year: 2013
  ident: BFjhh201559_CR10
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e328360ddd5
– volume: 65
  start-page: 547
  year: 2010
  ident: BFjhh201559_CR31
  publication-title: J Gerontol A Biol Sci Med Sci
  doi: 10.1093/gerona/glq030
– volume: 19
  start-page: 857
  year: 2001
  ident: BFjhh201559_CR21
  publication-title: J Hypertens
  doi: 10.1097/00004872-200105000-00004
– volume: 41
  start-page: 290
  year: 2013
  ident: BFjhh201559_CR30
  publication-title: Turk Kardiyol Dern Ars
  doi: 10.5543/tkda.2013.20025
– volume: 259
  start-page: 225
  year: 1988
  ident: BFjhh201559_CR3
  publication-title: JAMA
  doi: 10.1001/jama.1988.03720020027031
– volume: 114
  start-page: 3117
  year: 2009
  ident: BFjhh201559_CR35
  publication-title: Blood
  doi: 10.1182/blood-2009-02-203372
– volume: 47
  start-page: 1026
  year: 2013
  ident: BFjhh201559_CR17
  publication-title: Zhonghua Yu Fang Yi Xue Za Zhi
– volume: 16
  start-page: 429
  year: 2003
  ident: BFjhh201559_CR20
  publication-title: Am J Hypertens
  doi: 10.1016/S0895-7061(03)00566-1
– volume: 75
  start-page: 1184
  year: 2011
  ident: BFjhh201559_CR9
  publication-title: Circ J
  doi: 10.1253/circj.CJ-10-0638
– volume: 74
  start-page: 1399
  year: 1986
  ident: BFjhh201559_CR15
  publication-title: Circulation
  doi: 10.1161/01.CIR.74.6.1399
– reference: 12799089 - Am J Hypertens. 2003 Jun;16(6):429-33
– reference: 23949417 - Blood Press Monit. 2013 Oct;18(5):259-64
– reference: 20233513 - J Int Med Res. 2010 Jan-Feb;38(1):52-61
– reference: 21378450 - Circ J. 2011;75(5):1184-91
– reference: 21871091 - J Inflamm (Lond). 2011 Aug 26;8(1):22
– reference: 21196621 - Saudi J Kidney Dis Transpl. 2011 Jan;22(1):97-103
– reference: 16464884 - Nephrol Dial Transplant. 2006 Apr;21(4):850-3
– reference: 21737781 - Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2080-9
– reference: 22530956 - J Intern Med. 2012 Nov;272(5):484-91
– reference: 3536154 - Circulation. 1986 Dec;74(6):1399-406
– reference: 11679405 - Circ Res. 2001 Oct 26;89(9):763-71
– reference: 18049438 - Med Sci Monit. 2007 Dec;13(12):CR570-3
– reference: 11393667 - J Hypertens. 2001 May;19(5):857-61
– reference: 10775227 - BMJ. 2000 Apr 22;320(7242):1128-34
– reference: 18227483 - Diabetes Care. 2008 Feb;31 Suppl 2:S185-9
– reference: 7989463 - J Clin Endocrinol Metab. 1994 Dec;79(6):1605-8
– reference: 11230071 - BMJ. 2001 Mar 3;322(7285):531-6
– reference: 16481882 - Curr Opin Nephrol Hypertens. 2006 Mar;15(2):152-8
– reference: 24632958 - Int Heart J. 2014;55(2):160-4
– reference: 14665655 - JAMA. 2003 Dec 10;290(22):2945-51
– reference: 3336140 - JAMA. 1988 Jan 8;259(2):225-8
– reference: 18268038 - J Exp Med. 2008 Feb 18;205(2):339-46
– reference: 19567439 - JAMA. 2009 Jul 1;302(1):49-57
– reference: 23210729 - Blood Press. 2013 Jun;22(3):151-7
– reference: 23743803 - J Hypertens. 2013 Jul;31(7):1424-30; discussion 1430
– reference: 21524639 - J Am Soc Hypertens. 2011 Sep-Oct;5(5):395-400
– reference: 24507232 - Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Nov;47(11):1026-30
– reference: 22466361 - Anadolu Kardiyol Derg. 2012 Jun;12(4):298-304
– reference: 20203097 - J Gerontol A Biol Sci Med Sci. 2010 May;65(5):547-52
– reference: 23760115 - Turk Kardiyol Dern Ars. 2013 Jun;41(4):290-5
– reference: 19661270 - Blood. 2009 Oct 1;114(14 ):3117-26
– reference: 16478917 - J Leukoc Biol. 2006 May;79(5):909-12
– reference: 15492131 - Hypertension. 2004 Dec;44(6):859-65
– reference: 24436616 - Int J Angiol. 2013 Dec;22(4):223-8
– reference: 9727541 - Circulation. 1998 Aug 25;98(8):731-3
SSID ssj0014768
Score 2.2013988
Snippet An association has been described between inflammation and the progression of hypertension (HT) and is shown with several biochemical parameters. Our aim was...
SourceID proquest
gale
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 424
SubjectTerms 692/699/75/243
Adult
Arteriosclerosis
Biological markers
Biomarkers
Biomarkers - blood
Blood Pressure
C-reactive protein
C-Reactive Protein - analysis
Calcitonin
Calcitonin - blood
Cardiovascular diseases
Cardiovascular research
Carotid Intima-Media Thickness
Case-Control Studies
Comparative analysis
Diagnosis
Epidemiology
Female
Health Administration
Health aspects
Humans
Hypertension
Inflammation
Inflammation - blood
Inflammation - diagnosis
Inflammation - physiopathology
Inflammation Mediators - blood
Interleukin-33 - blood
Male
Medicine
Medicine & Public Health
Middle Aged
original-article
Pattern recognition receptors
Pentraxins
Procalcitonin
Public Health
Risk factors
Serum Amyloid P-Component - analysis
Up-Regulation
White Coat Hypertension - blood
White Coat Hypertension - diagnosis
White Coat Hypertension - physiopathology
Title Procalcitonin and Pentraxin-3: Current biomarkers in inflammation in white coat hypertension
URI https://link.springer.com/article/10.1038/jhh.2015.59
https://www.ncbi.nlm.nih.gov/pubmed/26040439
https://www.proquest.com/docview/1794490790
https://www.proquest.com/docview/2640630592
https://www.proquest.com/docview/1795867162
https://www.proquest.com/docview/1808622503
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS9xAEB_qCaUvpd_GWpuCpVDYmmR3k11fxBZFCoqUCvdQCNmPoEUSvTtp_3xnkr14Z61PIezcsjeZmf3NzscCbBmDm6TjlqVWJgzxv2PKK8OcUHVecKG5oGrko-P88FR8H8txOHCbhrTKuU3sDLVrLZ2Rb-PGTe2hpM52L68Y3RpF0dVwhcYKrKIJVnIEq1_3j09-DHEEUXTFcIgjEoaeRhIq9BKutn-fUSwilV-oTenCnnTXMi9sTXdipd0WdPAMngbsGO_1H_s5PPLNC3h8FKLjL-EXZf1XFxaVtDlv4qpx8Ul3ePv3vGF8Jw69mGIquaesnMk0RjIUMZSKvoKR3v9QYCG2bTWLz9BJnXQp7m3zCk4P9n9-O2Th9gRmpRAzJnStlNXOZLVDNxcfwmSFdxK1WqM_XXNpuasznxlXqVonWqXc5DbxhPmM5a9h1LSNX4MYIQx6OqISOjUC_UclUl-lXppE4499FsHnOf9KG1qL0w0XF2UX4uaqRGaXxOxS6gi2BuLLvqPG_WTv6UOUfTnooIflHiI-dEkLLv9LgaATUWhaJBF86ihIV3E9tgolB_ivqOvV0lwbS5SoY3Z5eC4OZdDxaUmmTGhkZnLv8K3ARvBhGKaJKa2t8e11N4WkBoP5QzSKvE5EqjyCN70kDnxDZ5S6IyGzPs5Fc2F9_zJ1_eGFvoUnSJj32cgbMJpNrv07xFwzswkrxbjYDOp1A45gKW8
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3ra9RAEF9qC-oX8W202ggtgrA2ye4mu4JI1Zar7R1FWugHYc0-QislqXdXqv-Uf6MzeXlXa7_1Uwg7WTaTefwmszNLyKox4CQdszS2IqKA_x2VXhrquCzSjHHFOFYjD0fp4IB_PhSHC-R3VwuD2yo7m1gbaldZ_Ee-Do4b20MJlbw__UHx1CjMrnZHaDRiseN_nUPINnm3_Qm-71qSbG3ufxzQ9lQBagXnU8pVIaVVziSFg_APLtwkmXcCpF1BnFkwYZkrEp8Yl8tCRUrGzKQ28oiFjGUw7w2yBDBDgRYtfdgc7X3p8xY8q4vvALdEFCKbqK0IjJhc_36EuY9YvMG2qDM-8KInmHGFF3KztcvbukvutFg13GiE6x5Z8OV9cnPYZuMfkK9YZZCfWDAK5XEZ5qUL9-qfxT-PS8rehm3vpxBL_HEX0HgSAhmINEhhUzGJ9-eYyAhtlU_DIwiKx_WW-qp8SA6uha-PyGJZlf4JCQEyQWTFc65iwyFelTz2eeyFiRQ87JOAvO74p23byhxP1DjRdUqdSQ3M1shsLVRAVnvi06aDx-VkK_ghdFN-2uu93gCECSFwxsR_KQDkAuqNsyggr2oKtA2wHpu3JQ7wVthla26u5TlK0Gk7P9yJg25tykSj6eQKmBldOvxXQQLysh_GiXEbXemrs3oKgQ0N06toJEa5gIxZQB43ktjzDYJf7MYEzFrrRHNmff8y9enVC10htwb7w129uz3aeUZuw0NpsxN6mSxOx2f-OeC9qXnRKllIvl23Xv8B3I9miQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9RAEB_qFYov4rfRaiO0CEK8JLt72RVEqu3RWnscYqEPhZjdbGilJPXuSvVf869zJtnEu1r71qcQdrJsJrMz88t8LMC61mgkc2aCyIgwQP8_D6SVOsi5LAYJ44pxqkbeHw12DvinQ3G4BL_bWhhKq2x1Yq2o88rQP_I-Gm5qDyVU3C9cWsR4a_j-7EdAJ0hRpLU9TqMRkT376wLh2_Td7hZ-6404Hm5__bgTuBMGAiM4nwVcFVIaleu4yBEK4oXrOLG5QMlXiDkLJgzLi9jGOs9koUIlI6YHJrTkF2nDcN5bsJzg0mQPlj9sj8ZfuhgGT-pCPPRhwgBRTuiqA0Mm-9-PKQ4SiTfUInXOHl62CnNm8VKctjZ_w7twx_mt_mYjaPdgyZb3YWXfReYfwBFVHGSnBhVEeVL6WZn74_rH8c-TMmBvfdcHyqdyf8oImkx9JEPxRolsqifp_oKCGr6pspl_jAB5UqfXV-VDOLgRvj6CXlmV9gn46D4hyuIZV5HmiF0lj2wWWaFDhQ_b2IPXLf9S49qa0-kap2kdXmcyRWanxOxUKA_WO-KzppvH1WRr9CHSphS10wHpJnqbCIcTJv5LgQ4vesBREnrwqqYgPYHrMZkrd8C3oo5bC3OtLlDi_jaLw604pE6_TFNSo1whM8Mrh_9uFg9edsM0MaXUlbY6r6cQ1NxwcB2NJMSLXjLz4HEjiR3fEAhTZyZk1kYrmnPr-5epT69f6Bqs4H5OP--O9p7BbXxm0CRFr0JvNjm3z9H1m-kXbo_58O2mt_UfjvVqtQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Procalcitonin+and+Pentraxin-3%3A+Current+biomarkers+in+inflammation+in+white+coat+hypertension&rft.jtitle=Journal+of+human+hypertension&rft.au=Yavuzer%2C+H&rft.au=Cengiz%2C+M&rft.au=Yavuzer%2C+S&rft.au=R%C4%B1za+Alt%C4%B1parmak%2C+M&rft.date=2016-07-01&rft.eissn=1476-5527&rft.volume=30&rft.issue=7&rft.spage=424&rft_id=info:doi/10.1038%2Fjhh.2015.59&rft_id=info%3Apmid%2F26040439&rft.externalDocID=26040439
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9240&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9240&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9240&client=summon